Assessing the long-term clinical benefit of prolonged-release fampridine tablets in a real-world setting: a review of 67 cases
Authors:
Open Access
- 1 October 2013
- journal article
- review article
- Published by Taylor & Francis in Patient Related Outcome Measures
- Vol. 4, 75-85
Abstract
Peer reviewed article authored by (Prugger M, Berger T). Read article or submit your manuscript for publishing.Keywords
This publication has 20 references indexed in Scilit:
- The impact of slower walking speed on activities of daily living in patients with multiple sclerosisInternational Journal Of Clinical Practice, 2012
- Social and economic burden of walking and mobility problems in multiple sclerosisBMC Neurology, 2012
- Treatment of walking impairment in multiple sclerosis: an unmet need for a disease-specific disabilityExpert Opinion on Pharmacotherapy, 2011
- Ambulatory Activity in Individuals With Multiple SclerosisJournal of Neurologic Physical Therapy, 2011
- The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disabilityBrain, 2010
- Contribution of impaired mobility and general symptoms to the burden of multiple sclerosisAdvances in Therapy, 2009
- Contribution of impaired mobility to patient burden in multiple sclerosisCurrent Medical Research and Opinion, 2009
- Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuableMultiple Sclerosis Journal, 2008
- The burden of multiple sclerosis: A community health surveyHealth and Quality of Life Outcomes, 2008
- Relapses and Progression of Disability in Multiple SclerosisNew England Journal of Medicine, 2000